Aprogen Pharmaceuticals Inc Cash Flow Quality Index
Aprogen Pharmaceuticals Inc cash flow quality index. Aprogen Pharmaceuticals Inc (003060) has a Cash Flow Quality Index of -13.36x as of March 2023. Operating cash flow of ₩-14.74 Billion is below net income of ₩1.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. See 003060 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Aprogen Pharmaceuticals Inc (2015–2022)
Cash flow quality index of Aprogen Pharmaceuticals Inc from 2015 to 2022. Historical Cash Flow Quality Index for Aprogen Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Aprogen Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Aprogen Pharmaceuticals Inc Cash Flow Quality Index by Year (2015–2022)
Aprogen Pharmaceuticals Inc cash flow quality index by year from 2015 to 2022. Year-by-year earnings quality comparison for Aprogen Pharmaceuticals Inc. For the full cash flow conversion analysis, see Aprogen Pharmaceuticals Inc (003060) cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.28x | ₩25.73 Billion | ₩7.84 Billion | ▲ +527.2% |
| 2021 | -0.77x | ₩-6.23 Billion | ₩8.10 Billion | ▼ -206.9% |
| 2020 | 0.72x | ₩8.09 Billion | ₩11.25 Billion | ▲ +7.4% |
| 2015 | 0.67x | ₩1.85 Billion | ₩2.76 Billion | — |